Yabao Pharmaceutical Group Co.,Ltd. Fundamental Rankings

This page is comprehensive fundamental data for Yabao Pharmaceutical Group Co.,Ltd.. Fundamentals are ordered by how Yabao Pharmaceutical Group Co.,Ltd. ranks compared to other companies (ordered high to low). All money values are in CNY. All data is powered by Quandl.

Cite in Wikipedia:

Indicator Value n/price Rank Date Historic
Selling expenses248,634,6180.032431042015-06-30historic
Payroll payable96,012,6620.012521112015-06-30historic
Proceeds from sell of investment534,056,3700.069651192015-06-30historic
Notes receivable197,933,9130.025822222015-06-30historic
Long term accounts payable18,715,9360.002442282015-06-30historic
Cash paid for dividends, profits or interests145,015,7720.018912322015-06-30historic
Fair value change gain-880,841-1.1E-42432015-06-30historic
Net income140,006,6670.018262592015-06-30historic
Cash paid for taxes144,703,0680.018872712015-06-30historic
Operating profit153,859,3030.020072792015-06-30historic
Total profit163,035,6160.021262802015-06-30historic
Total comprehensive income140,006,6670.018262812015-06-30historic
Fixed assets1,587,698,1260.207073012015-06-30historic
Short term borrowings800,278,2000.104373442015-06-30historic
Goodwill21,815,7050.002854112015-06-30historic
Non-operating loss1,469,3731.9E-44182015-06-30historic
Total non-current assets2,208,902,1180.288094472015-06-30historic
Financial expenses23,536,2190.003074472015-06-30historic
Other payables116,760,6280.015234652015-06-30historic
Net change in cash55,940,1770.00734662015-06-30historic
Prepayment93,940,3870.012254902015-06-30historic
Cash from other investing activities65,2981.0E-54972015-06-30historic
Long term borrowings78,035,0000.010185242015-06-30historic
Interests payable1,347,1041.8E-45402015-06-30historic
Intangible assets149,778,0650.019535532015-06-30historic
Revenue1,088,065,5830.141915532015-06-30historic
Purchases of fixed assets and others66,699,0980.00875592015-06-30historic
Total cost of goods sold946,974,2450.123515862015-06-30historic
Net cash flows from investing activities-55,060,669-0.007185982015-06-30historic
Total liabilities1,597,783,2740.208396092015-06-30historic
Accounts payable264,384,4590.034486222015-06-30historic
Cash inflows from operating activities932,533,1060.121626462015-06-30historic
Other receivables31,482,1940.004116722015-06-30historic
Cash inflows from financing activities398,044,8000.051916832015-06-30historic
Total liabilities and equity3,425,847,7810.446817032015-06-30historic
Cash outflows from operating activities774,203,6140.100977252015-06-30historic
Inventories330,624,6610.043127532015-06-30historic
Refunds of taxes293,1584.0E-57572015-06-30historic
Other current assets5,903,7897.7E-48962015-06-30historic
Comprehensive income attributable to minority shareholders-1,860,410-2.4E-49052015-06-30historic
Net cash and cash equivalents ending balance250,739,6430.03279172015-06-30historic
Minority interests gain-1,860,410-2.4E-49202015-06-30historic
Capital reserve402,234,3390.052469472015-06-30historic
Net cashflow from financing activities-47,020,211-0.006139622015-06-30historic
Disposal of fixed assets and others21,4840.09932015-06-30historic
Deferred tax assets4,277,4255.6E-410882015-06-30historic
Minority interest-1,330,907-1.7E-411062015-06-30historic
Diluted eps00.012112015-06-30historic